Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Fondazione Don Carlo Gnocchi ETS
With
Università Carlo Cattaneo , Castellanza
University of Milano Bicocca
Age
18–85
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
1. agreement to participate, with the signature of the informed consent form.
2. availability of a caregiver/study partner, who agrees to support the participant through the SIDERA\^B program.
3. living in one's own home.
4. clinical diagnosis of Chronic Heart Failure (CHF) and
1. functional New York Heart Association (NYHA) class II and III with an Ejection Fraction (EF) ≤ 40%
2. etiology of CHF primitive or post-ischemic.
5. clinical diagnosis of Chronic Obstructive Pulmonary Disease (COPD) and
1. COPD diagnosis according to the American Thoracic Society (ATS) and the European Respiratory Society (ERS) criteria with FEV1/FVC ratio \<70%
2. presence of airway limitation according to ATS/ERS and GOLD criteria.
6. clinical diagnosis of Parkinson Disease (PD) and
1. PD diagnosis according to the MDS criteria (Postuma et al., 2015)
2. staging between 1.5 and 3 on the Hoehn \& Yahr scale (Goetz et al., 2004)
7. age between 18 and 85 years.
You may not be if
1. presence of comorbidities that may prevent you from undertaking a secure home program or determining clinical instability (i.e. severe orthopedic or severe cognitive deficits).
2. presence of risk conditions for safety under strain in patients with CHF (i.e. severe symptomatic aortic stenosis, evidence of ischemia due to minimal/low-intensity efforts).
3. COPD patients who do not need rehabilitation treatment (GOLD 1 / A class) or with severe COPD (GOLD 4 / D class)
4. COPD patients with overlap with other respiratory diseases or not in treatment or in the absence of good ventilatory compensation in the last 6 months
5. COPD with global respiratory failure with PaCO2\> 55 mmHg
6. PD patients with other neurological pathologies or with severe psychiatric complications
7. pathological score to a screening test for cognitive impairment (Montreal Cognitive Assessment test - MoCA test \<17.54; Conti et al., 2015).
Clareo Health | An Innovative Disease-net Management Model for Non-communicable Diseases (SIDERA^B)
